These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
11. Evaluation of amastigote reactive cells in human cutaneous leishmaniasis caused by Leishmania aethiopica. Maasho K; McMahon-Pratt D; Raita J; Raud M; Britton S; Soong L; Akuffo H Clin Exp Immunol; 2003 May; 132(2):316-22. PubMed ID: 12699423 [TBL] [Abstract][Full Text] [Related]
12. Induction and abrogation of LACK reactive cells in the evolution of human leishmaniasis. Maasho K; Wolday D; Edjigu M; Söderström K; Britton S; Akuffo H Clin Exp Immunol; 2001 May; 124(2):255-61. PubMed ID: 11422202 [TBL] [Abstract][Full Text] [Related]
13. Evaluation of vaccinal effectiveness of preparations containing membrane antigens of Leishmania (L.) amazonensis in experimental cutaneous leishmaniasis model. Ribeiro JG; Ferreira AS; Macedo SRA; Rossi NRDLP; da Silva MCP; Guerra RNM; de Barros NB; Nicolete R Int Immunopharmacol; 2017 Jun; 47():227-230. PubMed ID: 28433944 [TBL] [Abstract][Full Text] [Related]
14. Differential effects of antigens from L. braziliensis isolates from disseminated and cutaneous leishmaniasis on in vitro cytokine production. Leopoldo PT; Machado PR; Almeida RP; Schriefer A; Giudice A; de Jesus AR; Ho JL; Guimarães LH; Bacellar O; Carvalho EM BMC Infect Dis; 2006 Apr; 6():75. PubMed ID: 16638143 [TBL] [Abstract][Full Text] [Related]
15. Efficacy of vaccination with a combination of Leishmania amastigote antigens and the lipid A-analogue ONO-4007 for immunoprophylaxis and immunotherapy against Leishmania amazonensis infection in a murine model of New World cutaneous leishmaniasis. Calvopina M; Barroso PA; Marco JD; Korenaga M; Cooper PJ; Nonaka S; Hashiguchi Y Vaccine; 2006 Jul; 24(27-28):5645-52. PubMed ID: 16621179 [TBL] [Abstract][Full Text] [Related]
16. Immunologic response and memory T cells in subjects cured of tegumentary leishmaniasis. Carvalho AM; Magalhães A; Carvalho LP; Bacellar O; Scott P; Carvalho EM BMC Infect Dis; 2013 Nov; 13():529. PubMed ID: 24206576 [TBL] [Abstract][Full Text] [Related]
17. A recombinant Leishmania antigen that stimulates human peripheral blood mononuclear cells to express a Th1-type cytokine profile and to produce interleukin 12. Skeiky YA; Guderian JA; Benson DR; Bacelar O; Carvalho EM; Kubin M; Badaro R; Trinchieri G; Reed SG J Exp Med; 1995 Apr; 181(4):1527-37. PubMed ID: 7699334 [TBL] [Abstract][Full Text] [Related]
18. Cytokine and nitric oxide patterns in dogs immunized with LBSap vaccine, before and after experimental challenge with Leishmania chagasi plus saliva of Lutzomyia longipalpis. Resende LA; Roatt BM; Aguiar-Soares RD; Viana KF; Mendonça LZ; Lanna MF; Silveira-Lemos D; Corrêa-Oliveira R; Martins-Filho OA; Fujiwara RT; Carneiro CM; Reis AB; Giunchetti RC Vet Parasitol; 2013 Dec; 198(3-4):371-81. PubMed ID: 24129068 [TBL] [Abstract][Full Text] [Related]
19. Antigenic extracts of Leishmania braziliensis and Leishmania amazonensis associated with saponin partially protects BALB/c mice against Leishmania chagasi infection by suppressing IL-10 and IL-4 production. Grenfell RF; Marques-da-Silva EA; Souza-Testasicca MC; Coelho EA; Fernandes AP; Afonso LC; Rezende SA Mem Inst Oswaldo Cruz; 2010 Sep; 105(6):818-22. PubMed ID: 20944999 [TBL] [Abstract][Full Text] [Related]
20. Can interferon-gamma and interleukin-10 balance be associated with severity of human Leishmania (Viannia) braziliensis infection? Gomes-Silva A; de Cássia Bittar R; Dos Santos Nogueira R; Amato VS; da Silva Mattos M; Oliveira-Neto MP; Coutinho SG; Da-Cruz AM Clin Exp Immunol; 2007 Sep; 149(3):440-4. PubMed ID: 17614975 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]